CAD 0.06
(20.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 4.4 Million CAD | 6.44% |
2022 | 4.13 Million CAD | -28.25% |
2021 | 5.76 Million CAD | 128.94% |
2020 | 2.51 Million CAD | 145.36% |
2019 | 1.02 Million CAD | 36.88% |
2018 | 749.83 Thousand CAD | 2616.2% |
2017 | 27.6 Thousand CAD | 85.03% |
2016 | 14.92 Thousand CAD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 5.15 Million CAD | 6.36% |
2024 Q1 | 4.84 Million CAD | 10.0% |
2024 Q3 | 4.31 Million CAD | -16.32% |
2023 Q4 | 4.4 Million CAD | 14.17% |
2023 Q3 | 3.85 Million CAD | 2.9% |
2023 FY | 4.4 Million CAD | 6.44% |
2023 Q1 | 4.38 Million CAD | 5.92% |
2023 Q2 | 3.74 Million CAD | -14.46% |
2022 FY | 4.13 Million CAD | -28.25% |
2022 Q3 | 3.98 Million CAD | -2.4% |
2022 Q2 | 4.08 Million CAD | -5.07% |
2022 Q1 | 4.3 Million CAD | -25.31% |
2022 Q4 | 4.13 Million CAD | 3.7% |
2021 Q4 | 5.76 Million CAD | 6.59% |
2021 Q3 | 5.4 Million CAD | 18.43% |
2021 Q2 | 4.56 Million CAD | 232.69% |
2021 FY | 5.76 Million CAD | 128.94% |
2021 Q1 | 1.37 Million CAD | -45.49% |
2020 Q3 | 1.14 Million CAD | -13.52% |
2020 FY | 2.51 Million CAD | 145.36% |
2020 Q4 | 2.51 Million CAD | 120.49% |
2020 Q2 | 1.32 Million CAD | 13.43% |
2020 Q1 | 1.16 Million CAD | 13.45% |
2019 Q4 | 1.02 Million CAD | 13.01% |
2019 Q3 | 908.22 Thousand CAD | -26.08% |
2019 Q2 | 1.22 Million CAD | 28810.12% |
2019 Q1 | 4250.00 CAD | -70.3% |
2019 FY | 1.02 Million CAD | 36.88% |
2018 Q1 | - CAD | -100.0% |
2018 Q2 | 27.6 Thousand CAD | 0.0% |
2018 Q3 | 30.49 Thousand CAD | 10.47% |
2018 Q4 | 14.31 Thousand CAD | -53.08% |
2018 FY | 749.83 Thousand CAD | 2616.2% |
2017 Q3 | 21.02 Thousand CAD | 0.0% |
2017 FY | 27.6 Thousand CAD | 85.03% |
2017 Q4 | 1352.00 CAD | -93.57% |
2016 FY | 14.92 Thousand CAD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Aion Therapeutic Inc. | 2.93 Million CAD | -49.953% |
Ayurcann Holdings Corp. | 14.31 Million CAD | 69.248% |
Blueberries Medical Corp. | 470.72 Thousand CAD | -835.445% |
The BC Bud Corporation | 626 Thousand CAD | -603.407% |
BioNxt Solutions Inc. | 6.55 Million CAD | 32.775% |
CordovaCann Corp. | 11.29 Million CAD | 61.001% |
Christina Lake Cannabis Corp. | 8.5 Million CAD | 48.202% |
Captor Capital Corp. | 28.76 Million CAD | 84.692% |
City View Green Holdings Inc. | 3.73 Million CAD | -17.958% |
1CM Inc. | 9.42 Million CAD | 53.274% |
Global Hemp Group Inc. | 5.82 Million CAD | 24.408% |
Greenway Greenhouse Cannabis Corporation | 21.17 Million CAD | 79.204% |
IM Cannabis Corp. | 35.11 Million CAD | 87.459% |
Lobe Sciences Ltd. | 2.45 Million CAD | -79.026% |
Maple Leaf Green World Inc. | 10.08 Million CAD | 56.32% |
Mountain Valley MD Holdings Inc. | 258 Thousand CAD | -1606.726% |
Ovation Science Inc. | 728.99 Thousand CAD | -504.033% |
Pharmadrug Inc. | 2.92 Million CAD | -50.518% |
Captiva Verde Wellness Corp. | 2.08 Million CAD | -110.792% |
RAMM Pharma Corp. | 2.83 Million CAD | -55.293% |
RIV Capital Inc. | 275.63 Million CAD | 98.402% |
Revive Therapeutics Ltd. | 3.4 Million CAD | -29.361% |
Red White & Bloom Brands Inc. | 364.63 Million CAD | 98.792% |
SLANG Worldwide Inc. | 37.58 Million CAD | 88.284% |
1933 Industries Inc. | 23.28 Million CAD | 81.088% |
Red Light Holland Corp. | 3.82 Million CAD | -15.221% |
Top Strike Resources Corp. | 20.99 Million CAD | 79.026% |
Xebra Brands Ltd. | 789.95 Thousand CAD | -457.418% |
Adastra Holdings Ltd. | 17.65 Million CAD | 75.063% |